Complicated Crohn's-like colitis, associated with Hermansky-Pudlak syndrome, treated with Infliximab: a case report and brief review of the literature

• Published in: Journal of medical case reports 2007-12, Vol.1 (1), p.176-176, Article 176
• Main Authors: Kouklakis, George, Efremidou, Eleni I, Papageorgiou, Michael S, Pavlidou, Evdoxia, Manolas, Konstantinos J, Liratzopoulos, Nikolaos
• Format: Article
• Language: English
• Subjects: Analysis; Care and treatment; Case Report; Case studies; Colonoscopy; Complications and side effects; Crohn's disease; Diagnosis; Health aspects; Risk factors
• ISSN: 1752-1947; 1752-1947
• DOI: 10.1186/1752-1947-1-176

Hermansky-Pudlak syndrome (HPS) is a rare autosomal recessive inherited disorder consisting of a triad of albinism, increased bleeding tendency secondary to platelet dysfunction, and systemic complications associated with ceroid depositions within the reticuloendothelial system. HPS has been associated with gastrointestinal (GI) complications related to chronic granulomatous colitis with pathologic features suggestive of Crohn's disease. This colitis can be severe and has been reported to be poorly responsive to medical therapies including antibiotics, corticosteroids, sulfasalazine, mesalamine and azathioprine. We report a patient with HPS which was complicated by inflammatory bowel disease with clinical and pathologic features of Crohn's disease, refractory to antibiotics, corticosteroids and azathioprine. A trial of infliximab was attempted and repeated infusions produced a complete response. The occurrence of ileitis and perianal lesions and also the histopathological findings in our case suggest that HPS and Crohn's disease may truly be associated. Given this similarity and the failure of the standard medical therapy of corticosteroids and azathioprine, our patient received infliximab with marked clinical improvement.